TRDA · Entrada Therapeutics, Inc.
$7.46
+0.01 (+0.13%)
At close · Aug 14
Market Cap
$290.47M
Shares
38.94M
Entrada Therapeutics, Inc. Earnings Call Transcripts
Every quarterly earnings call for Entrada Therapeutics, Inc. (TRDA) — the full transcript with speaker labels, the audio replay, AI call highlights and a management-tone score, plus the matching 8-K earnings release and the quarter's 10-Q or 10-K. Investor days and conferences appear here too.
Revenue & result across quarters
Revenue Net income YoY up YoY down artefacts
Earnings call
FY26 · Q1
2026-05-07
Entrada Therapeutics, Inc. Q1 FY2026 Earnings Call
Confident tone
ENTR 60144 / DMD exon 44 skipping
Safety and functional benefit in DMD
Dose escalation and registrational dose selection
Revenue
$875,000
▼ 95.7% YoY Diluted EPS
$-0.95
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY25 · Q4
2026-01-08
Entrada Therapeutics, Inc. Q4 FY2025 Earnings Call
Revenue
$1.30M*
▼ 96.5% YoY
Rev · 8q
Audio
Transcript
Slides
8-K10-K
Showing 1–2 of 2 earnings calls
Key facts
CIK
1689375
CUSIP
29384C108
13F (30d)
123 filings
122 filers
Visit website
Investor relations